Who We Fund
Since 1949, LLS has provided more than $1.7 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Affimed
immunotherapy, HL, PTCL
Armin Rashidi
gut bacteria and transplant success
Alec Zhang
myeloma, immunotherapy
Timothy Ley
AML, precision medicine
Tyler Parsons
MPN and AML
Gianpietro Dotti
CAR T and AML
Eric Padron
CMML
Lakshmi Nayak
brain tumors in lymphoma
Gaurav Goyal
Erdheim-Chester Disease
Katherine Borden
AML
Riccardo Dalla-Favera
lymphoma (DLBCL)
Nitin Jain
CLL
Omar Abdel-Wahab
Hairy cell leukemia
Mitchell Geer
leukemia biology
Mark Dawson
B-ALL and CAR-T resistance
Elliot Stieglitz
CMML
Tanya Siddiqi
clinical trial access
Koichi Takahashi
AML/MDS
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
Mark Hamilton
DLBCL and CAR-T
Joachim Yahalom
Lymphoma
G. Greg Wang
DNA biology
Jing Yang
Myeloma
Yubin Zhou
peripheral T cell lymphoma
Stephen Gottschalk
pediatric leukemia and CAR-T
Vittoria Biotherapeutics
immunotherapy, CAR-T, TCL
Venkata Lokesh Battula
immunotherapy and AML
Sam Butterworth
CMML
Robert Soiffer
transplantation
Britta Will
Leukemia and pre-leukemia
Thorsten Zenz
Hairy cell leukemia
Neha Mehta-Shah
T-cell lymphoma
Inhye Ahn
CLL
Robert Bradley
MDS
Zhijian Qian
blood cancer stem cells
Steven Horwitz
T-cell lymphomas
Julia Maxson
AML
Kimberly Stegmaier
childhood blood cancers
Pietro Genovese
transplant and AML
Jaroslaw Maciejewski
bone marrow failure
Juliette Bouyssou
leukemias and gender
Stephen Oh
myeloproliferative neoplasms
Reshmi Parameswaran
immunotherapy for hairy cell leukemia
Kura Oncology
MLL leukemia, AML
Oreofe Odejide
Equity in Access
David Fruman
novel combinations
Helen Parsons
Equity in Access
Todd Fehniger
NK/CART cell therapy for lymphomas and pediatric AML
Maximilian Stahl
AML immunotherapy
Rgenta Therapeutics
RNA-targeting, blood cancer
Mala Shanmugam
myeloma
Roland Walter
Antibody-based AML therapies
Shannon McKinney-Freeman
transplant biology
Eirini Papapetrou
blood cancer stem cells
Qingyu Luo
BPDCN
Keisuke Ito
blood cancer stem cells and MDS metabolism
Qing Yi
Novel CAR-T
Craig Jordan
AML
Catriona Jamieson
cancer stem cell biology
William Matsui
Myeloma
John Crispino
MPNs, myelofibrosis
ImCheck Therapeutics
immunotherapy, AML
Jaehyuk Choi
T-cell lymphoma
F. Lennie Wong
Equity in Access
Siddhartha Jaiswal
preleukemia
Jennifer Trowbridge
aging and leukemia
Christiane Querfeld
T-cell lymphoma
Meng Li
Equity in Access
Julia Paczkowska
immunobiology of Hodgkin's disease
Bruno Paiva
smoldering myeloma
Arash Alizadeh
blood cancer biology and diagnosis
Jennifer Woyach
CLL trials
Alison Moskowitz
lymphoma therapeutics
Carl Allen
pediatric blood cancers
Brian Walker
smoldering myeloma, MGUS
Sergei Doulatov
Leukemias
Catherine Bollard
pediatric blood cancers and immunotherapy
Lori Muffly
Equity in Access
Nizar Bahlis
Myeloma immunotherapy
George Vassiliou
Leukemia Prevention
Randall Davis
CLL
Thomas Koehnke
leukemia
Sarah Tasian
pediatric leukemias
Nicolas Nassar
pediatric leukemia
Jonathan Licht
DNA biology, myeloma
Richard Lock
T-ALL
Kathleen Sakamoto
pediatric AML
Alexey Danilov
lymphoma
Maria "Ken" Figueroa
aging and leukemia
Peter Klein
MDS
Lawrence Boise
CART and myeloma
Xu Ji
Equity in Access
Eugenio Morelli
Myeloma
Eric Pietras
AML
Christopher Booth
BPDCN
Ari Melnick
epigenetics and lymphoma
Matteo Bellone
Smoldering multiple myeloma
Aditi Shastri
AML, MDS
Selina Chen-Kiang
Mantle cell lymphoma
Abintus Bio
immunotherapy, in vivo CAR
Zachary Hunter
Waldenström macroglobulinemia (WM)
Markus Muschen
leukemia and lymphoma biology
Courtney Jones
AML metabolism
Jalpa Doshi
Equity in Access
Adi Nagler
Bronchiolitis obliterans after transplant
Enterome
vaccine, FL, MZL
Stacie Dusetzina
Equity in Access
Jeffrey Magee
pediatric AML
Daniel Lucas
bone marrow and leukemia biology
Thomas LeBlanc
palliative care
Kirk Schultz
pediatric transplantation
Megan McNerney
AML/MDS
Soheil Meshinchi
pediatric AML
Lev Kats
myeloma and epigenetics
Kymera Therapeutics
protein degraders, TCL, LGLL, AML
Marco Ruella
Immunotherapy for T-cell lymphoma
Ravi Bhatia
transplantation
Justine Kahn
pediatric leukemia and lymphoma
Dan Landau
cancer evolution biology
Courtney DiNardo
clinical trials, AML
Caroline Arber
myeloma CAR-T
Christopher Flowers
clinical trial access
Madhav Dhodapkar
multiple myeloma immunotherapy
Jennifer Lewis
URM Student
Amit Verma
AML/MDS
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Sisi Chen
leukemia
Luca Busino
DLBCL
Carl June
CAR T immunotherapy
Adam de Smith
pediatric ALL and Down Syndrome
Susan Schwab
cancer immunology
Piers Patten
COVID-19
Frederike Kramer
MPNs
Michael Kharas
leukemia
Alex Kentsis
pediatric leukemias
David Ritchie
Hairy Cell Leukemia
Shannon Maude
Immunotherapy for ALL
Jayna Mistry
aging and leukemias
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
Samuel Taylor
leukemia biology
Ryan Wilcox
T-cell lymphoma
Ravindra Majeti
preleukemia, AML
John Pimanda
AML, MDS
Paolo Strati
Non-Hodgkin Lymphoma
Daisuke Nakada
preleukemia, leukemia
Adam Olszewski
Follicular and marginal zone lymphoma
Suman Paul
T cell cancers and immunotherapy
Lucy Godley
preleukemia
Robert Orlowski
(Smoldering) Multiple Myeloma
Michael Rout
follicular lymphoma, CAR T
Cailin Collins
Leukemia and pre-leukemia
Daniel Thomas
Myelofibrosis
Amer Zeidan
MDS and AML
Jonathon Cohen
lymphoma clinical trial access in Georgia
Dimericon Therapeutics
dimericons, blood cancer
Liling Wan
AML
Jianguo Tao
Mantle Cell Lymphoma
Jun Qi
Myeloma
Nathan Ungerleider
lymphoma biology
Yan Liu
MDS
Jian Xu
leukemia and MPN biology
Immune-Onc Therapeutics
immunotherapy, AML, CMML
Dane Vassiliadis
blood cancer biology
Amin Sobh
Myeloma biology
Rajni Kumari
AML
Baochun Zhang
immunotherapy
Kasey Leger
pediatric blood cancers
Roberta Zappasodi
lymphoma, immunotherapy
Daniel Starczynowski
MDS and AML
Thomas Kipps
Hairy Cell Leukemia
Kehan Ren
MDS
Sameer Parikh
COVID-19
Shirong Li
myeloma
Ryvu Therapeutics
AML, MDS
Ruben Carrasco
Myeloma
Stephen Nimer
myeloid cancer biology
Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's
Alex Herrera
lymphoma and immunotherapy
Jolanta Grembecka
leukemia therapeutics
Jason Butler
aging and leukemia
Jonas Jutzi
myeloproliferative neoplasms
Ann-Kathrin Eisfeld
Racial diversity in AML
Christopher Reilly
leukemia
Alexandra Stevens
childhood AML
Jenny Wang
AML
Ronald Levy
immunotherapies, COVID-19
Frederick Locke
lymphoma and immunotherapy
Dan Vogl
myeloma, microenvironment
Tomasz Skorski
myeloproliferative neoplasms, AML
Zachary Epstein-Peterson
Peripheral T-cell lymphoma trial
Timothy Graubert
AML and MDS biology
Alieen Rowan
Adult T cell leukemia/lymphoma
Kirsten Williams
leukemia, immunotherapy
Yiman Liu
Epigenetics and leukemia
Brian Dalton
DNA mutations and myeloid cancers
Steven Treon
Lymphomas and Waldenstrom's
Huda Salman
CMML
Christian Marinaccio
MLL leukemias
Marina Konopleva
MDS/AML metabolism
Kevin Shannon
pediatric AML
Jianhua Yu
myeloma immunotherapy
Yibin Yang
Lymphoma
Hao Jiang
leukemia biology
Robert Kridel
follicular lymphoma
Therese Vu
T-All and MLL
Michael Savona
MDS and leukemia
Constellation Pharmaceuticals
myeloproliferative neoplasms
Catherine Smith
leukemia
Helen Heslop
Immunotherapy
Areej El-Jawahri
transplant survivorship
Daniel Pollyea
AML
Takeshi Sugio
T-cell lymphoma
Noemí Puig Morón
Myeloma
Alfred Garfall
myeloma immunotherapy
Christopher Porter
Leukemia, lymphoma
Liran Shlush
pre-leukemia
Dren Bio
immunotherapy, cytotoxic lymphomas, LGLL
Wendy Stock
T-cell ALL
Christine Zhang
AML
Lindsey Montefiori
pediatric leukemia
Sylvain Simon
Immunotherapy, CAR-T safety
Sattva Neelapu
DLBCL, CAR T
Martin Dreyling
Mantle Cell Lymphoma
Tycel Phillips
Mantle Cell Lymphoma
Simona Colla
Myeloma biology
Grzegorz Nowakowski
Clinical trial access
Sami Malek
blood cancer biology
Gareth Morgan
smoldering myeloma, MGUS
Matthew Frank
Lymphoma CART therapy
Andrew Lane
BPDCN
Rizwan Romee
Immunotherapy
Daniel Herranz
T-ALL
Peng Ji
myeloproliferative neoplasms
Hong Wen
AML
Margaret Shipp
lymphoma biology
Sean Post
diffuse large B-cell lymphoma
BioInvent International
immunotherapy, indolent NHL, CTCL
Logan Spector
childhood leukemia epidimiology
Caner Saygin
T-ALL
Tak Mak
Immunotherapy
Taishi Yonezawa
AML
Michael Wang
Mantle Cell Lymphoma
Ricky Johnstone
lymphoma and myeloma
Enrico Tiacci
Hairy cell leukemia
Michael Keller
COVID-19, immunotherapy
Sahand Hormoz
MPN
Mendel Goldfinger
MDS/AML trials for the elderly
Grant Challen
preleukemia, leukemia
Larry Kwak
Mantle cell lymphoma, immunotherapy
Coleman Lindsley
AML/MDS
Faron Pharmaceuticals
immunotherapy, MDS
Patrizia Mondello
IgM MGUS & Waldenstrom Macroglobulinemia
Srividya Swaminathan
pediatric, immunotherapy
Michael Green
lymphoma biology
Saar Gill
AML immunotherapy
Caron Jacobson
lymphoma and immunotherapy
Sigurður Kristinsson
Smoldering myeloma
Jessica Stewart
Epstein-barr virus and lymphomas
Trent Hall
MDS
Jeremy Baeten
AML
Wendy Béguelin
follicular lymphoma
John Leonard
lymphoma research
Yusuke Isshiki
DLBCL and GCB Lymphomas
Suzanne Lentzsch
Myeloma
Christian Steidl
B-cell lymphomas
Marc Seifert
Hairy cell leukemia
Lei Ding
myeloproliferative neoplasms, myelofibrosis
Anna Lee
AML
Kerry Rogers
CLL
Rong Lu
preleukemia, leukemia
Nirav Shah
CAR-T for lymphoma
